Abstract:Background Hepatic stellate cells, the major providers of hepatic retinoids and extracellular matrix (ECM), reside in the space of Disse filled with loose basement like ECM, and flanked by hepatocytes and sinusoidal endothelial cells. Upon hepatic injury, stellate cells are activated to express multiple matrix metalloproteinases (MMPs) and to mobilize retinoids for wound healing. In chronic injury, the quiescent stellate cells undergo trans‐differentiation into myofibroblast like cells, marked by loss of retinoids, expression interstitial ECM as well as smooth muscle actin (alpha‐SMA), and gain of contractibility. Although knowledge has been evolved substantially, two fundamental questions remain largely unknown as to how, in normal liver, HSCs maintain quiescence, and how, by injury, HSCs are activated within the ECM milieu. Results To recapitulate the sub‐sinusoid microenvironment we embedded rat primary stellate cells in three‐dimensional ECM (3D ECM). Cultured on plastic, the stellate cells activated spontaneously, showing loss of vitamin A droplets and expression of alpha‐SMA. However, in 3D Matrigel, stellate cells retained retinoid droplets, in association with elevated level of lecithin retinoid acyltransferase (LRAT), a key enzyme for retinol esterification. In 3D ECM, stellate cells were arrested at G0/G1 phase, while on plastic the cells underwent cell cycling and stopped at G2/M phase. We then reconstituted the microenvironment of sinusoids by introducing Kupffer cells, the major hepatic inflammatory cells, into 3D ECM with HSCs. Activated Kupffer cells triggered subsequent activation of stellate cells, evidenced by expression of multiple MMPs, buildup of stress fibers, and loss of retinoids. The Kupffer cell‐mediated activation of stellate cells was blocked by interleukin‐1 receptor antagonist, demonstrating interleukin‐1 as a major injury signal from Kupffer cells conducting stellate cell activation and trans‐differentiation. Furthermore, within 3D ECM, but not on the plastic, interleukin‐1 signal was greatly amplified by stellate cells in an autocrine manner, which may exacerbate liver injury by expressing MMPs in the space of Disse. The myofibroblastic cells derived from the 3D ECM culture were contractile in response to endothelin. Conclusion The 3D ECM culture provides a model to simulate key physiological functions of stellate cells in normal liver, and also to recapitulate patho‐physiological responses in liver injury. The method may also be used in cell‐based drug screening to identify components targeting liver failure and fibrosis. Support or Funding Information National Institutes of Health (NIH) Grants R01s, DK069418‐05 and AR051558, and the Natural Science Foundation of China This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis

Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition

In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line

The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model

Assessment of fibrotic pathways induced by environmental chemicals using 3D-human liver microtissue model.

Amplified Response of Drug-Induced Liver Fibrosis via Immune Cell Co-Culture in a 3D In Vitro Hepatic Fibrosis Model

Fibroblast activation in response to TGFβ1 is modulated by co-culture with endothelial cells in a vascular organ-on-chip platform

Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic Organoids

Cultivation of Hepatic Stellate Cells in 3D ECM to Simulate Physiological and Fibrotic Conditions

Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease

Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis

Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model

Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution

Human iPSC-derived liver co-culture spheroids to model liver fibrosis

Modeling the profibrotic microenvironment in vitro: Model validation

A rule-based multiscale model of hepatic stellate cell plasticity: critical role of the inactivation loop in fibrosis progression

Multi-omics profiling of primary hepatic stellate cells from advanced liver fibrosis patients reveals distinctive molecular signatures

Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors